Coronary Vasomotor Response After Riociguat Exposure
Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess the effects of intracoronary Riociguat on coronary blood
flow in subjects with coronary artery disease and to compare this effect with the
intracoronary nitroglycerin, a coronary vasodilator widly used to treat patients with
coronary artery disease.